🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Hans Carl Hasselbalch

University of Copenhagen

ORCID: 0000-0003-3936-8032

Also affiliated with Sankt Hans Hospital, Zealand University Hospital

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 3 papers. Top paper: Ruxolitinib is manageable in patients with myelofibrosis and severe thrombocytopenia: a report on 12 Danish patients.

18 citations

Morten Orebo Holmström, Hans Carl Hasselbalch, Mads Emil Bjørn

64 citations

Vibe Skov, Kristen E. Stevenson, Lillian Werner, William S. Duke, Charles Laurore +27 more

1 citations

Katalin Veres, Hans Carl Hasselbalch, Henrik Frederiksen, Lene Sofie Granfeldt Østgård, Erzsébet Horváth–Puhó +3 more